ARCHIVES

Irinotecan And Carboplatin Improve Response In NSCLC

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

Genomic Tests Not Shown To Decrease Deaths, Improve Quality Of Life

October 27, 2006

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

All 59 CCOP Awards Announced Heavy In Northeast, Fair In Midwest; Amounts, Priority Scores Listed

June 3, 1983

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975

Funding Opportunities

January 10, 2003

Rauscher May Set Up New Office To Monitor, Coordinate RFPs And Grants, Stop Duplication

May 2, 1975